AZN
$48.36
Astrazeneca Plc
$.44
.92%
AZN
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.48
Revenue:  $6.55 Bil
Thursday
Jan 23
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when AZN reports earnings?
Beat
Meet
Miss

Where is AZN's stock price going from here?
Up
Flat
Down
Stock chart of AZN
Analysts
Summary of analysts' recommendations for AZN
Score
Grade
Pivots
Resistance
$48.95
$48.77
$48.56

$48.38

Support
$48.18
$48.00
$47.79
Tweet
Growth
Description
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.